Latest Articles

Publication Date
Official report condemns ‘medical misogyny’ around endometriosis and other conditions - Mancunian Matters

Official report condemns ‘medical misogyny’ around endometriosis and other conditions Mancunian Matters

Published: Dec. 12, 2024, 9:35 a.m.
Crossed 35? You Need To Watch Your Weight To Reduce Breast Cancer Risk - Medical Daily

Crossed 35? You Need To Watch Your Weight To Reduce Breast Cancer Risk Medical Daily

Published: Dec. 12, 2024, 9:31 a.m.
Young Mom Diagnosed With Stage 4 Breast Cancer Weeks After Clear Mammogram Reveals Overlooked Symptoms - Medical Daily

Young Mom Diagnosed With Stage 4 Breast Cancer Weeks After Clear Mammogram Reveals Overlooked Symptoms Medical Daily

Published: Dec. 12, 2024, 6:34 a.m.
Boost in Women's Diagnostic Imaging Access - Mirage News

Boost in Women's Diagnostic Imaging Access Mirage News

Published: Dec. 12, 2024, 5:38 a.m.
Molecular-genetic characteristics of hmgb1 mrna expression in blood of women with endometriosis associated with infertility.

Aim: To examine HMGB1 expression in the blood of women with endometriosis-associated infertility and to establish its role in disease progression.

Published: Dec. 12, 2024, midnight
Missing and dismissing the impact of periods. Outcomes of focus groups of teens with period concerns.

Despite a high prevalence, menstrual issues are often normalised or trivialised and undermanaged in young people (YP). Uncontrolled dysmenorrhoea and heavy menstrual bleeding have a vastly negative impact on the …

Published: Dec. 12, 2024, midnight
N6-Methyladenosine Modification on the Function of Female Reproductive Development and Related Diseases.

N6-methyladenosine (m6A) modification is a widespread and reversible epigenetic alteration in eukaryotic mRNA, playing a pivotal role in various biological functions. Its significance in female reproductive development and associated diseases …

Published: Dec. 12, 2024, midnight
The oral GnRH antagonists, a new class of drugs in gynecology: from pharmacokinetics to possible clinical applications.

In ovarian steroid-dependent diseases such as uterine fibroids, endometriosis and adenomyosis, oral GnRH antagonists have emerged as new therapeutic alternatives. These oral GnRH antagonists offer key advantages, including oral administration, …

Published: Dec. 12, 2024, midnight
Postmenopausal endometriosis.

Published: Dec. 12, 2024, midnight
Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis.

Endometriosis affects over 190 million women globally, and effective therapies are urgently needed to address the burden of endometriosis on women's health. Using an artificial intelligence (AI)-driven target discovery platform, …

Published: Dec. 12, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!